 |
| EUROPE: Chemical Law Has Global Impact
by Lyndsey Layton, Washington Post
June 12th, 2008
Europe this month rolled out new restrictions on makers of chemicals linked to cancer and other health problems. The changes follow eight years of vigorous opposition from the U.S. chemical industry giants like DuPont, and the Bush administration. |
| TOBACCO: Profits in Hand, Wealthy Family Cuts Tobacco Tie
by STEPHANIE SAUL, The New York Times
June 11th, 2008
Now, the next generation of Tisches has removed tobacco from the portfolio of the conglomerate they lead, the Loews Corporation, spinning off its tobacco unit, Lorillard, as a stand-alone business, with the Newport brand representing more than 90 percent of the new company’s revenue. The new stock began trading Tuesday, and analysts have said the new company might be a takeover target. |
| US: Researchers Fail to Reveal Full Drug Pay
by GARDINER HARRIS and BENEDICT CAREY, The New York Times
June 8th, 2008
A world-renowned Harvard child psychiatrist whose work has helped fuel an explosion in the use of powerful antipsychotic medicines in children earned at least $1.6 million in consulting fees from drug makers from 2000 to 2007 but for years did not report much of this income to university officials, according to information given Congressional investigators. |
| US: Former Colo. nuke plant contractors ordered to pay $925M
AP
June 3rd, 2008
Two companies that worked as contractors with the now-defunct Rocky Flats nuclear weapons plant have been ordered to pay $925 million to residents who claimed that contamination blown from the facility endangered people's health and devalued their property. |
| US: Exxon investors reject green initiatives
by Andrew Clark, The Guardian
May 29th, 2008
The world's biggest oil company emerged bruised but victorious from a bust-up with the billionaire Rockefeller family yesterday as an effort to foist green initiatives on ExxonMobil failed to capture wholehearted support from shareholders. |
| US: Drug Makers Near Old Goal: A Legal Shield
by GARDINER HARRIS and ALEX BERENSON, The New York Times
April 6th, 2008
The Bush administration has argued strongly in favor of the doctrine, which holds that the F.D.A. is the only agency with enough expertise to regulate drug makers and that its decisions should not be second-guessed by courts. The Supreme Court is to rule on a case next term that could make pre-emption a legal standard for drug cases. The court already ruled in February that many suits against the makers of medical devices like pacemakers are pre-empted. |
| US: Reynolds Ads Oppose Move to Regulate Tobacco
by STEPHANIE SAUL, The New York Times
April 1st, 2008
As legislation moves through Congress that would empower the F.D.A. to regulate the tobacco industry, Reynolds, whose brands include Camel cigarettes, is attacking what it views as the bill’s vulnerability: a weak, overextended F.D.A. |
|
|
